Quantcast

Global Pharmaceutical Contract Manufacturing Market

December 9, 2013

Reportbuyer.com just published a new market research report: Global Pharmaceutical Contract Manufacturing Market.

London (PRWEB) December 09, 2013

Injectable Dose Formulations will Likely Spur the Growth of CMOs

Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companies can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the pharmaceutical contract manufacturing market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, Scandinavia, and Rest of World are covered. The period covered in the study is from 2009 to 2017, with the base year of 2012.

Methodology

-Primary interviews were conducted with industry stakeholders such as Tier I and Tier II contract manufacturing organisations (CMOs), pharmaceutical and biotech companies, industry experts, and regulatory authorities. Designation of interviewed participants include chief executive officers, marketing managers, directors, and vice presidents.

-Secondary research sources such as in-house Frost & Sullivan database, Frost & Sullivan’s Decision Support Database, company annual reports, scientific journals, and industry-related articles have been utilised.

-For the purpose of this research, pharmaceutical contract manufacturing refers to secondary manufacturing of finished dose formulations for small molecules. Manufacturing of active pharmaceutical ingredients (APIs) and intermediates are excluded.

-Revenues are from contract manufacturing and development services such as formulation, pre-formulation, packaging, testing, validation, regulatory, optimisation, and fill and finish services.

-Over-the-counter (OTC) products have not been included in the scope of this study.

Market Segmentation

The pharmaceutical contract manufacturing market can be broadly divided into 3 main segments: Solid dose formulations, liquid and semi-solid dose formulations, and injectable dose formulations.

-Solid dose formulations comprise basic (tablets and capsules) and advanced (controlled-release), fast-dissolving, and soft-gel, which are multi-active pharmaceutical ingredient (API) oral finished dose formulations.

-Liquid and semi-solid dose formulations include nasal, nebulized, ophthalmic, otic, and topical formulations, including sterile and non-sterile preparations.

-Injectable dose formulations are sterile preparations, including small- and large-volume parenterals. Small-volume parenterals are of 2 types: cytotoxic and non-cytotoxic.

CEO’s Perspective

-Lyophilisation and manufacturing of sterile products such as cytotoxics will likely be areas of growth potential, given the demand for oncology and high-potency drugs.

-The pharmaceutical contract manufacturing market is highly fragmented, and consolidation is required to improve profitability.

-Thirty percent of existing participants could exit the market due to pricing pressure and low profit margins, mainly in the liquid and semi-solid dose formulations segment.

-Capturing projects at the early life-cycle stage of products and a risk-sharing business model can help build long-term strategic relationships.

Key Findings

-In 2012, the global pharmaceutical contract manufacturing market generated $xx billion in revenue. The forecast shows a compound annual growth rate (CAGR) of xx% from 2012 to 2017.

oThe injectable dose formulations segment will likely be the primary growth driver for outsourcing throughout the forecast period.

-In 2012, solid dose formulations was the largest segment, constituting xx% of the total pharmaceutical contract manufacturing market, and is projected to grow at a CAGR of xx% from 2012 to 2017.

oGenerics will likely be a key growth driver for the solid dose formulations segment; however, this segment will likely lose shares to the injectable dose formulations segment because of big pharma’s shift in focus from small molecules to large molecules.

-Injectable dose formulations is the fastest growing segment and is projected to register a robust CAGR ofxx% from 2012 to 2017.

oKey growth drivers include increased pharmaceutical and biotechnological focus on complex disease areas, trends in disease control, growth in emerging markets, the pharmaceutical patent cliff (several blockbuster drugs losing patent protection), and reformulation of existing products.

oThe major growth contributor is expected to be cytotoxics as both cancer research and the development of new cancer therapies are driving growth in this area.

-The liquid and semi-solid dose formulations segment is quite mature and expected to experience a relatively lower CAGR of xx% from 2012 to 2017.

oDecreasing demand for liquid dose formulations is primarily attributed to transportation, storage, and packaging issues associated with these formulations as well as lower returns compared to injectable dose formulations manufacturing.

oThe sterile liquid and semi-solid dose preparations, particularly nasal ophthalmic dose formulations, are expected to experience strong growth; however, these preparations currently constitute a very small segment of the market.

-Because of big pharma’s increased outsourcing, the pharmaceutical contract manufacturing market is expected to show consistent growth. CMOs are striving to provide greater value proposition for clients by engaging in the early life-cycle stage projects and establishing long-term relationships.

oTo improve their value proposition to manufacturers, many CMOs are focusing on pre-clinical development services and can transition from offering clinical services to offering commercial manufacturing to integrate throughout the value chain of clients.

-Industry consolidation is on an increasing curve. The fragmented market nature will likely intensify pricing pressure and drive down CMO revenues.

-Catalent Inc., Patheon Inc., and Aenova (with the acquisition of the Temmler group) are the top xxmarket participants, constituting a combined share ofxx% in the global pharmaceutical contract manufacturing market.

Key Questions This Study Will Answer

-Is the pharmaceutical contract manufacturing market growing, how long will it continue to grow and at what rate?

-What are the fastest growing segments of the pharmaceutical contract manufacturing market?

-What opportunities exist in the pharmaceutical contract manufacturing industry?

-What are the key drivers and restraints affecting the growth of the CMOs?

-What are the key challenges the CMOs will likely face in the near and long-term future?

-In what ways is the pharmaceutical contract manufacturing industry likely to change to meet industry challenges?

Executive Summary

Scope and Segmentation

Market Segmentation

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Findings

Key Companies to Watch

Executive Summary—3 Big Predictions

The Last Word—Discussion

Market Overview

Market Segmentation

Segmentation by Manufacturing Process

Segmentation by Patent Exclusivity Status

Global Market Perspective

Defining CMO Trends in the Future

Competitive Playbook

New Market Opportunities

Key Merger, Acquisition and Partnership Assessment

Drivers, Restraints, and Trends—Total Pharmaceutical Contract Manufacturing Market

Market Drivers

Market Restraints

Market Impact of Key Drivers and Restraints

Forecasts and Trends—Total Pharmaceutical Contract Manufacturing Market

Market Engineering Measurements

Forecast Assumptions

Revenue Forecast

Revenue Forecast Discussion

Percent Revenue Forecast by Region

Revenue Forecast by Region

Key Market Trends

Key Technology Trends

Market Impact of Key Trends

Venture Capital Trends in CMO

Segment Lifecycle Analysis

End-User Analysis/Demand Analysis—Total Pharmaceutical Contract Manufacturing Market

End-user Survey Objectives

End-user Survey Methodology

Outsourcing Trend Analysis by Company Type

Number of CMOs Companies Work With and by Company Type

End-user Classification Based on CMO Use

End-user Breakdown by Company Type

Criteria for CMO Selection

Top 5 Factors for CMO Selection

Top 5 Factors for CMO Selection Discussion

Stated Versus Unstated Importance of Selection Factors

Stated Versus Unstated Importance of Selection Factors Discussion

Extent of Outsourcing to CMOs by Service Areas

Analysis of Outsourcing Budget Based on Product Revenue

Outsourcing of Pharmaceutical Manufacturing Demand Forecast

Industry Capacity Utilisation Forecast

Industry Capacity Utilisation Forecast Discussion

Market Share and Competitive Analysis—Total Pharmaceutical Contract Manufacturing Market

Market Share

Market Share Analysis

CMO Breakdown by Finished Dose Segments

Solid Dose Formulations Segment Breakdown

Solid Dose Formulations Segment Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Breakdown

Liquid and Semi-solid Dose Formulations Segment Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

Injectable Dose Formulations Segment Breakdown

Injectable Dose Formulations Segment Key Findings

Market Engineering Measurements

Revenue Forecast

Revenue Forecast Discussion

United States Breakdown

US Pharmaceutical Contract Manufacturing Market—Market Engineering Measurements

US Pharmaceutical Contract Manufacturing Market Revenue Forecast

US Pharmaceutical Contract Manufacturing Market Revenue Forecast Discussion

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Pricing Analysis

Market Analysis

PESTLE Analysis

Europe Breakdown

European Pharmaceutical Contract Manufacturing Market—Market Engineering Measurements

European Pharmaceutical Contract Manufacturing Market Revenue Forecast

European Pharmaceutical Contract Manufacturing Market Revenue Forecast Discussion

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Pricing Analysis

Market Analysis

PESTLE Analysis

United Kingdom Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Germany Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

France Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Italy Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Spain Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Scandinavia Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Benelux Breakdown

Solid Dose Formulations Segment Revenue Forecast

Solid Dose Formulations Segment Revenue Forecast Discussion

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast

Liquid and Semi-solid Dose Formulations Segment Revenue Forecast Discussion

Injectable Dose Formulations Segment Revenue Forecast

Injectable Dose Formulations Segment Revenue Forecast Discussion

Key Companies to Watch

Key Companies to Watch

Catalent

Patheon

Aenova

Famar

Fareva

Haupt Pharma AG

Recipharm AB

DPT Laboratories

Aesica

Baxter BioPharma Solutions

Vetter Pharma

Hospira One 2 One

NextPharma Technologies

The Last Word

The Last Word—Three Big Predictions

The Last Word—Discussion

Legal Disclaimer

Appendix

Market Background

Important Market Metrics

Market Landscape and Pricing

Drivers Explained

Restraints Explained

US Patent Expiration Timetable

Europe Patent Expiration Timetable

Decision Support Database—Total Healthcare Expenditure

Decision Support Database—Public Healthcare Expenditure

Decision Support Database—Private Healthcare Expenditure

Additional Sources of Information on Contract Outsourcing Services

List of Other Key Companies Included in this Research Service

Market Engineering Methodology

Learn More—Next Steps

List of Figures

Total Pharmaceutical Contract Manufacturing Market: Market Segmentation, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Segments, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Manufacturing Process, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Sales Breakdown by Patent Exclusivity Status, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Revenue Breakdown by Geographic Region, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Market Outlook, Global, 2012 and 2022

Total Pharmaceutical Contract Manufacturing Market: Game-changing Strategies, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Market Outlook, Global, 2010–2012

Total Pharmaceutical Contract Manufacturing Market: Key Market Drivers, Global, 2013–2017

Total Pharmaceutical Contract Manufacturing Market: Key Market Restraints, Global, 2013–2017

Total Pharmaceutical Contract Manufacturing Market: Impact of Key Drivers and Restraints, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Revenue Forecast, Global, 2009–2017

Total Pharmaceutical Contract Manufacturing Market: Percent Points Comparison with the US, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Points Manufacturing Cost Comparison with the US, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Points Labour Cost Comparison with the US, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Revenue Forecast by Region, Global, 2009–2017

Total Pharmaceutical Contract Manufacturing Market: Revenue Forecast by Region, Global, 2009–2017

Total Pharmaceutical Market: Combined Prescription Sales for the Top 50 Pharmaceutical Companies by Molecule Type, Global, 2012–2017

Total Pharmaceutical Market: Combined Prescription Sales for the Top 50 Pharmaceutical Companies by Therapeutic Area, Global, 2012–2017

Pharmaceutical Contract Manufacturing Market: Percent of Combined Prescription Sales for Big Pharmaceutical Companies by Molecule Type, Global, 2012–2017

Pharmaceutical Contract Manufacturing Market: Percent of Combined Prescription Sales for Mid-sized Pharmaceutical Companies by Molecule Type, Global,

2012–2017

Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Activities Outsourced, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: CAGRs of Segments Likely to Have Higher Levels of Outsourcing, Global, 2012–2019

Total Pharmaceutical Contract Manufacturing Market: Market Impact of Key Trends, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Segment Lifecycle Analysis, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Finished Dose Manufacturing Outsourced by Company Type, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Number of CMOs Companies Work With, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Number of CMOs Companies Work With by Company Type, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: End-user Percent Breakdown by CMO Budget, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: End-user Percent Breakdown by Company Type, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Customer Utility Value of Various Factors Involved in the Selection of a CMO, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Top 5 Factors for CMO Selection, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Percent Breakdown of Top 5 Factors for CMO Selection by Company Type, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Extent of Outsourcing to CMOs by Service Areas, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Extent of Outsourcing to CMOs by Service Areas, Global, 2017

Total Pharmaceutical Contract Manufacturing Market: Percent Outsourcing Budget Allocation Based on Product Revenue, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Outsourcing of Pharmaceutical Manufacturing Demand Forecast, Global, 2012–2017

Total Pharmaceutical Contract Manufacturing Market: Industry Capacity Utilization Forecast, Global, 2012–2017

Total Pharmaceutical Contract Manufacturing Market: CMO Market Share, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: CMO Market Share Analysis, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: CMO Breakdown by Finished Dose Segments, Global, 2012

Solid Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012

Solid Dose Formulations Segment: Market Engineering Measurements, Global, 2012

Solid Dose Formulations Segment: Revenue Forecast, Global, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012

Liquid and Semi-solid Dose Formulations Segment: Market Engineering Measurements, Global, 2012

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Global, 2009–2017

Injectable Dose Formulations Segment: Percent Sales Breakdown by Sub-segments, Global, 2012

Injectable Dose Formulations Segment: Market Engineering Measurements, Global, 2012

Injectable Dose Formulations Segment: Revenue Forecast, Global, 2009–2017

Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, US, 2012

Pharmaceutical Contract Manufacturing Market: Revenue Forecast, US, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, US, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, US,

2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, US, 2009–2017

Pharmaceutical Contract Manufacturing Market: Pricing Analysis, US, 2012

Pharmaceutical Contract Manufacturing Market: PESTLE Analysis, US, 2012

Pharmaceutical Contract Manufacturing Market: Market Engineering Measurements, Europe, 2012

Pharmaceutical Contract Manufacturing Market: Revenue Forecast, Europe,

2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Europe, 2009–2017

Pharmaceutical Contract Manufacturing Market: Pricing Analysis, Europe, 2012

Pharmaceutical Contract Manufacturing Market: PESTLE Analysis, Europe, 2012

Solid Dose Formulations Segment: Revenue Forecast, United Kingdom, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast,

United Kingdom, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, United Kingdom,

2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Germany, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, France, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, France, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, France, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Italy, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Italy,

2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Italy, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Spain, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Spain,

2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Spain, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Scandinavia, 2009–2017

Solid Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017

Liquid and Semi-solid Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017

Injectable Dose Formulations Segment: Revenue Forecast, Benelux, 2009–2017

Total Pharmaceutical Contract Manufacturing Market: Important Market Growth Metrics, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: Client-wise Revenue Contribution to CMOs, Global, 2012

Total Pharmaceutical Contract Manufacturing Market: VC Investment in Pharmaceutical/Biotech Companies and CMOs, Global, 2000–2011

Total Pharmaceutical Contract Manufacturing Market: Key Blockbuster Drugs Losing Patent Protection, US, 2012–2017

Total Pharmaceutical Contract Manufacturing Market: Key Blockbuster Drugs Losing Patent Protection, Europe, 2010–2017

Decision Support Database: Total Healthcare Expenditure, Global, 2008-2018

Decision Support Database: Public Healthcare Expenditure, Global, 2008-2018

Decision Support Database: Private Healthcare Expenditure, Global, 2008-2018

Read the full report:

Global Pharmaceutical Contract Manufacturing Market

http://www.reportbuyer.com/industry_manufacturing/manufacturers/global_pharmaceutical_contract_manufacturing_marketn.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com/

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/12/prweb11404286.htm


Source: prweb



comments powered by Disqus